What is HealthEquity Inc's share price today?
HealthEquity Inc (HQY) share price today is $103.61 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $103.99 and a day low of $101.22.What exchange does HealthEquity Inc stock trade on, and under what ticker symbol?
HealthEquity Inc stock trades on NASDAQ under the ticker symbol HQY.What is HealthEquity Inc's market capitalization?
HealthEquity Inc's market capitalization is $9B as of November 7, 2026 at 2:29 AM IST.What is HealthEquity Inc's price-to-earnings (P/E) ratio?
HealthEquity Inc's price-to-earnings (P/E) ratio is 39.29 as of November 7, 2026.What is HealthEquity Inc's price-to-book (P/B) ratio?
HealthEquity Inc's price-to-book (P/B) ratio is 4.24 as of November 7, 2026.Can Indian investors buy HealthEquity Inc shares?
Yes, You can buy HealthEquity Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in HealthEquity Inc shares from India?
Indian investors can buy HealthEquity Inc shares in three steps: 1. Search HealthEquity Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from HealthEquity Inc shares for Indian investors?
Since HealthEquity Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in HealthEquity Inc shares via Tickertape?
Indian investors can start investing in HealthEquity Inc (HQY) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0965 shares at the current price of $103.61.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 15 analysts reports
Price Upside
+16.44%
Earnings Growth
+17.82%
Rev. Growth
+7.87%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
The next fiscal year's mean estimate implies 7.87% growth, versus a trailing 3-year CAGR of 15.08%.
All values in $ Billion
All values in $ Billion
Earnings Per Share Forecast
Earnings Per Share Forecast
The next fiscal year's mean estimate implies 17.82% growth, versus a trailing 3-year CAGR of 43.75%.
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 287.59 | 299.92 | 300.43 | 311.81 | 330.84 | 325.83 | 322.16 | 334.58 | 354.64 | 350.73 |
| Gross Profit | 161.59 | 173.07 | 168.67 | 189.24 | 197.30 | 205.59 | 201.06 | 309.15 | 256.31 | 257.95 |
| Net Income | 28.81 | 35.82 | 5.70 | 26.36 | 53.91 | 59.85 | 51.69 | 49.74 | 69.41 | 65.64 |
| Net Profit Margin | 10.01% | 11.94% | 1.89% | 8.45% | 16.29% | 18.36% | 16.04% | 14.86% | 19.57% | 18.71% |
Peers
Peers & Comparison
Peers & Comparison
HealthcareHealth Information Services
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| HealthEquity Inc | 39.29 | 4.24 | 1.25 |
| UnitedHealth Group Incorporated | 23.36 | 3.48 | 1.02 |
| Elevance Health Inc | 18.43 | 2.00 | 1.26 |
The 12-month consensus target implies 16.44% growth, versus a trailing 3-year CAGR of 15.54%.